Clinicopathological Characteristics and Recurrence Patterns of Olfactory Neuroblastoma: A 15-Year Tertiary Center Case Series.
6 affiliations
- 1Department of Otorhinolaryngology-Head and Neck Surgery Tehran University of Medical Sciences Tehran Iran tums.ac.ir.
- 2Orphans Worldwide Jacksonville Florida USA.
- 3Department of Pathology Tehran University of Medical Sciences Tehran Iran tums.ac.ir.
- 4Eswatini Antivenom Foundation Simunye Eswatini.
- 5Mayo Clinic Jacksonville Florida USA mayo.edu.
- 6Rhinology Research Society Tehran Iran.
Abstract
Objectives
Olfactory neuroblastoma (ONB) is a rare malignant tumor of the sinonasal tract with heterogeneous clinical behavior and recurrence potential. Due to its low incidence, prognostic factors and optimal treatment strategies remain incompletely defined. The objective of this study was to describe the clinicopathological characteristics, treatment approaches, and recurrence patterns of ONB over a 15-year period at a tertiary referral center.Methods
A retrospective case series and literature review were performed. Medical records of nine patients with histologically confirmed ONB treated between 2007 and 2022 were reviewed. Demographic characteristics, presenting symptoms, imaging findings, Hyams histologic grade, treatment modalities, and follow-up outcomes were analyzed. Diagnosis in every case rested on characteristic morphology together with a full neuroendocrine immunohistochemical panel, and Hyams grade was assigned on the definitive resection specimen. Variables that were not uniformly documented across the 15-year archive-clinical stage, surgical margin status and the anatomical compartment of recurrence-were deliberately not imputed and are reported as unavailable.Results
Patients ranged in age from 18 to 61 years (mean 41.3 ± 12.4 years; median 42 years), with a male predominance (6/9, 66.7%). The most common presenting symptoms were nasal congestion, headache, and nasal mass. All patients underwent surgical resection with curative intent, predominantly through endoscopic endonasal approaches, followed by adjuvant chemoradiotherapy. Within a uniform, protocol-defined posttreatment observation window of 3 years (median follow-up 36 months), tumor recurrence occurred in 4 of 9 patients (44.4%), and 5 of 9 patients (55.6%) remained free of documented recurrence. Recurrence was observed across different Hyams grades, including grade I tumors, without a statistically significant association between histologic grade, age, or gender and recurrence.Conclusions
ONB demonstrates variable clinical presentation and recurrence patterns, even following multimodal treatment. Histologic grade alone may not reliably predict recurrence in small cohorts. Recurrence despite low-grade histology and uniformly administered chemoradiotherapy supports grade-, stage-, and margin-adapted rather than uniform adjuvant strategies, and structured surveillance continued well beyond 5 years.
Related
- Early Versus Late Recurrence in Olfactory Neuroblastoma: A Multi‐Institutional Analysis of Predictive Risk Factors
- Clinicopathological features, recurrence patterns, and survival outcomes of triple-negative ductal carcinoma in situ: a single-center cohort study.
- Real-World Clinicopathological Characteristics, Metastatic Distribution, and Treatment Patterns of Triple-Negative Breast Cancer: A Single-Institution Experience from Nigeria
- An interpretable machine-learning signature predicts early triple-negative breast cancer recurrence but adds no prognostic value beyond clinicopathological factors in external validation
- Clinicopathological predictors and an internally validated exploratory nomogram for 2-year recurrence after hepatic resection of hepatocellular carcinoma ≤5 cm.
BibTeX
@article{naraghi2026clinicopathological,
title = {{Clinicopathological Characteristics and Recurrence Patterns of Olfactory Neuroblastoma: A 15-Year Tertiary Center Case Series.}},
author = {Mohsen Naraghi and Maryam Lotfi and Lindelwa Phakamile Mmema and Jazmin Kazravan and Amirhossein Babaei},
journal = {Case reports in otolaryngology},
year = {2026},
month = oct,
doi = {10.1155/crot/4417318},
url = {https://europepmc.org/article/MED/42898551},
note = {CC BY},
}
RIS
TY - JOUR
TI - Clinicopathological Characteristics and Recurrence Patterns of Olfactory Neuroblastoma: A 15-Year Tertiary Center Case Series.
AU - Mohsen Naraghi
AU - Maryam Lotfi
AU - Lindelwa Phakamile Mmema
AU - Jazmin Kazravan
AU - Amirhossein Babaei
PY - 2026
DA - 2026/10/18
JO - Case reports in otolaryngology
DO - 10.1155/crot/4417318
UR - https://europepmc.org/article/MED/42898551
AB - Objectives Olfactory neuroblastoma (ONB) is a rare malignant tumor of the sinonasal tract with heterogeneous clinical behavior and recurrence potential. Due to its low incidence, prognostic factors and optimal treatment strategies remain incompletely defined. The objective of this study was to describe the clinicopathological characteristics, treatment approaches, and recurrence patterns of ONB over a 15-year period at a tertiary referral center.Methods A retrospective case series and literature review were performed. Medical records of nine patients with histologically confirmed ONB treated between 2007 and 2022 were reviewed. Demographic characteristics, presenting symptoms, imaging findings, Hyams histologic grade, treatment modalities, and follow-up outcomes were analyzed. Diagnosis in every case rested on characteristic morphology together with a full neuroendocrine immunohistochemical panel, and Hyams grade was assigned on the definitive resection specimen. Variables that were not uniformly documented across the 15-year archive-clinical stage, surgical margin status and the anatomical compartment of recurrence-were deliberately not imputed and are reported as unavailable.Results Patients ranged in age from 18 to 61 years (mean 41.3 ± 12.4 years; median 42 years), with a male predominance (6/9, 66.7%). The most common presenting symptoms were nasal congestion, headache, and nasal mass. All patients underwent surgical resection with curative intent, predominantly through endoscopic endonasal approaches, followed by adjuvant chemoradiotherapy. Within a uniform, protocol-defined posttreatment observation window of 3 years (median follow-up 36 months), tumor recurrence occurred in 4 of 9 patients (44.4%), and 5 of 9 patients (55.6%) remained free of documented recurrence. Recurrence was observed across different Hyams grades, including grade I tumors, without a statistically significant association between histologic grade, age, or gender and recurrence.Conclusions ONB demonstrates variable clinical presentation and recurrence patterns, even following multimodal treatment. Histologic grade alone may not reliably predict recurrence in small cohorts. Recurrence despite low-grade histology and uniformly administered chemoradiotherapy supports grade-, stage-, and margin-adapted rather than uniform adjuvant strategies, and structured surveillance continued well beyond 5 years.
SN - 2090-6765
SN - 2090-6773
ER -